Performance of private sector health care: implications for universal health coverage

Article English OPEN
Morgan, R ; Ensor, T ; Waters, H (2016)
  • Publisher: Elsevier
  • Subject:
    mesheuropmc: health care economics and organizations

Although the private sector is an important health-care provider in many low-income and middle-income countries, its role in progress towards universal health coverage varies. Studies of the performance of the private sector have focused on three main dimensions: quality, equity of access, and efficiency. The characteristics of patients, the structures of both the public and private sectors, and the regulation of the sector influence the types of health services delivered, and outcomes. Combined with characteristics of private providers—including their size, objectives, and technical competence—the interaction of these factors affects how the sector performs in different contexts. Changing the performance of the private sector will require interventions that target the sector as a whole, rather than individual providers alone. In particular, the performance of the private sector seems to be intrinsically linked to the structure and performance of the public sector, which suggests that deriving population benefit from the private health-care sector requires a regulatory response focused on the health-care sector as a whole.
  • References (50)
    50 references, page 1 of 5

    1. Bennett S, Hanson K, Kadama P, Montagu D. Working with the Non-State Sector to Achieve Public Health Goals. Geneva: World Health Organization, 2005.

    2. Mackintosh M, Selveraj S, Channon A, Zhao H, Cavagnero E, Karan A. What is the private systems. Lancet. 2016;xxx.

    3. Basu S, Andrews J, Kishore S, Panjabi R, Stuckler D. Comparative Performance of Private and Public Healthcare Systems in Low- and Middle-Income Countries: A Systematic Review. Plos Medicine. 2012;9(6):e1001244.

    4. Berendes S, Heywood P, Oliver S, Garner P. Quality of Private and Public Ambulatory Health Care in Low and Middle Income Countries: Systematic Review of Comparative Studies. Plos Medicine. 2011;8(4):e1000433.

    5. Bhatia J, Cleland J. Health care of female outpatients in south-central India: comparing public and private sector provision. . Health Policy and Planning. 2004;19(6):402-6.

    6. Brugha R. Antiretroviral Treatment in Developing Countries: The Peril of Neglecting Private Providers. British Medical Journal. 2003;326:1382-4.

    7. Nyazema N, Khosa S, Landman I, Sibanda E, Gael K. Antiretroviral (ARV) drug utilization in Harare. Central African Journal of Medicine. 2000;46(4):89-93.

    8. Gbotosho GO, Happi CT, Ganiyu A, Ogundahunsi OA, Sowunmi A, Oduola AM. Potential contribution of prescription practices to the emergence and spread of chloroquine resistance in south-west Nigeria: caution in the use of artemisinin combination therapy. Malaria Journal. 2009;8(313).

    9. Gupta S, Gunter JT, Novak RJ, Regens JL. Patterns of Plasmodium vivax and Plasmodium falciparum malaria underscore importance of data collection from private health care facilities in India. Malaria Journal. 2009;8(227).

    10. Gwatkin DR, Rutstein S, Johnson K, Suliman E, Wagstaff A, Amouzou A. Socio-economic Differences in Health, Nutrition, and Population within Developing Countries An Overview. Produced by the World Bank in collaboration with the Government of the Netherlands and the Swedish International Development Cooperation Agency, 2007.

  • Related Research Results (2)
  • Metrics
    views in OpenAIRE
    views in local repository
    downloads in local repository

    The information is available from the following content providers:

    From Number Of Views Number Of Downloads
    White Rose Research Online - IRUS-UK 0 449
Share - Bookmark